Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M47.2Revenue (TTM) $M5.8Net Margin (%)-16.4Altman Z-Score2.6
Enterprise Value $M47.6EPS (TTM) $-0.0Operating Margin %-12.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)-16.4Higher ROA y-yN
Price/Book9.710-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsY
Price/Sales8.55-y EBITDA Growth Rate %--Current Ratio1.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-115.4ROA % (ttm)-8.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-19.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M65.4ROIC % (ttm)-16.8Gross Margin Increase y-yY

Gurus Latest Trades with IGXT

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

IGXT is held by these investors:



IGXT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boudreau BernardDirector 2016-11-30Sell25,000$0.75-4view
Durham John EdwardVP Manufacturing 2016-10-07Buy3,000$0.76-5.26view
Durham John EdwardVP Manufacturing 2016-09-21Buy10,000$0.83-13.25view
Godin AndreEVP & CFO 2016-09-14Buy20,000$0.720view
Boudreau BernardDirector 2016-01-22Buy65,000$0.4946.94view
Bechard Robert J.VP Corporate Development 2016-01-22Buy10,000$0.544view
Godin AndreEVP + CFO 2016-01-20Buy20,000$0.480view
Godin AndreEVP & CFO 2015-12-30Buy9,500$0.5238.46view
Godin AndreEVP + CFO 2015-12-23Buy15,350$0.5141.18view
Godin AndreEVP + CFO 2015-12-22Buy19,650$0.544view

Press Releases about IGXT :

Quarterly/Annual Reports about IGXT:

News about IGXT:

Articles On GuruFocus.com
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT® for Migraines in Luxembo Apr 13 2017 
IntelGenx and RedHill Biopharma Announce Signing of Definitive Agreement for Commercialization of RI Jul 05 2016 
IntelGenx Reports Amendment of Stock Option Plan May 12 2016 
IntelGenx Reports First Quarter 2016 Financial Results May 10 2016 
IntelGenx to Report First Quarter 2016 Financial Results on May 10, 2016 May 05 2016 
IntelGenx and RedHill Biopharma Announce RIZAPORT(TM) Commercialization Term Sheet With Grupo Juste Mar 29 2016 
IntelGenx Announces Development and Commercialization Term Sheet with a Global Pharmaceutical Compan Mar 24 2016 
IntelGenx to Host Conference Call and Webcast of Fourth Quarter and Full-Year 2015 Financial Results Mar 09 2016 
IntelGenx Appoints Dr. Dana Matzen as Vice President, Business Development Mar 02 2016 
IntelGenx Announces USPTO Has Granted Patent Protecting RIZAPORT(TM) Oral Film for Migraines Feb 18 2016 

More From Other Websites
IntelGenx reports 1Q loss May 11 2017
IntelGenx Reports First Quarter 2017 Financial Results May 11 2017
Investor Network: Intelgenx Technologies Corp. to Host Earnings Call May 11 2017
IntelGenx to Report First Quarter 2017 Financial Results on May 11, 2017 - Conference Call to Follow May 04 2017
RedHill Biopharma Reports 2017 First Quarter Financial Results May 03 2017
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT® for Migraines in... Apr 13 2017
IntelGenx and RedHill Biopharma Announce Marketing Approval of RIZAPORT(R) for Migraines in... Apr 13 2017
IntelGenx Files Preliminary Short Form Prospectus in Connection With a Proposed Offering of... Apr 05 2017
IntelGenx Presents at the 13th International Conference on Alzheimer's and Parkinson's Diseases Apr 04 2017
IntelGenx and Tetra Bio-Pharma Announce the Signing of a Definitive Agreement for the Development... Apr 03 2017
IntelGenx Technologies Corp. :IGXT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 30, 2017 Mar 30 2017
IntelGenx Reports Fourth Quarter and Full-Year 2016 Financial Results Mar 28 2017
Oral Film Exclusivity Granted to IntelGenx' VersaFilm(TM) for Tadalafil Erectile Dysfunction Dosing... Mar 28 2017
IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 -... Mar 21 2017
IntelGenx Engages Kilmer Lucas for Cross-Border Investor Relations Mar 13 2017
Research Reports Initiated on Healthcare Stocks Aphria, Antibe Therapeutics, BriaCell Therapeutics,... Mar 07 2017
IntelGenx and Tetra Bio-Pharma Announce the Signing of a Term Sheet for the Development and... Feb 09 2017
IntelGenx Presentation Now Available for On-Demand Viewing Feb 06 2017
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present... Jan 30 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat